Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22964354 | 0.85 | SLC2A1 (0.51) | SLC2A1CYP2D6HRH3ALDH1A1TP53 | |
| SCHEMBL16150040 | 0.83 | SLC2A1 (0.49) | SLC2A1CYP2D6HRH3ALDH1A1TP53 | |
| SCHEMBL21477274 | 0.82 | CYP2D6 (0.46) | SLC2A1CYP2D6DHFRDCPSALDH1A1 | |
| SCHEMBL16030943 | 0.81 | SLC2A1 (0.48) | SLC2A1CYP2D6DHFRDCPSHRH3 | |
| SCHEMBL13724855 | 0.79 | CYP2D6 (0.52) | SLC2A1CYP2D6ALDH1A1TP53CYP3A4 | |
| SCHEMBL3098610 | 0.79 | CHRNB4 (0.57) | SLC2A1CYP2D6ALDH1A1TP53CYP3A4 | |
| SCHEMBL14048250 | 0.79 | TP53 (0.49) | SLC2A1CYP2D6DHFRDCPSALDH1A1 | |
| SCHEMBL16031257 | 0.79 | CYP2D6 (0.46) | SLC2A1CYP2D6DHFRDCPSALDH1A1 | |
| SCHEMBL1278162 | 0.77 | TDP1 (0.53) | CYP2D6 | |
| SCHEMBL4933694 | 0.77 | MCHR1 (0.46) | SLC2A1CYP2D6HRH3ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961231-B2 | NTCP inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-03-30 | — | — | US | disclosed |
| US-20210040072-A1 | NTCP Inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040072-A1 | NTCP Inhibitors | HAVCR2, NPC1, HMGCR | SLC2A1 742/4885CYP2D6 1410/4885DHFR 80/4885 |
| US-10961231-B2 | NTCP inhibitors | HAVCR2, NPC1, HMGCR | SLC2A1 742/4885CYP2D6 1410/4885DHFR 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.